Search results for: 'CHINA pharmaceutical market'

16 Aug 2016  |  North America  |  Market Research

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

Infographics

×

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The scale and sophistication of cyberattacks in China continue to rise, driven by the rapid adoption of cloud computing, mobile applications, IoT devices, and industrial digitalization. Increasing automation of attacks, combined with wider use of AI-driven intrusion techniques, is placing unprecedented pressure on organizations to strengthen visibi...

China’s passenger vehicle navigation on autopilot (NOA) market is entering a phase of accelerated commercialization, scaling from 2.4 million units in 2025 to 15.0 million by 2032, reflecting a strong 29.8% CAGR. This surge marks a decisive transition from early-adopter experimentation to mass-market deployment, fueled by factory-fitted hardware st...

This Frost & Sullivan analysis examines the telematics sector in China, with a specific focus on commercial trucks. The data presented here refers to the total installed base of telematics, equivalent to the total number of commercial trucks that are subscribed to telematics. This includes historical data from 2021. The base year for this analysis ...

China is entering a decade of macroeconomic transformation, with growth expected to moderate from an average of 5.7% between 2015 and 2025 to 3.7% between 2025 and 2035. This slowdown is being driven by structural factors like population aging, property sector correction, and shifting global trade dynamics. In this scenario, China is accelerating i...

The study provides an overview of the off-highway equipment market in China, with a specific focus on construction, mining, and agriculture.China has a large population of 1.4 billion people, a vast geographical area, and rich natural resources. Key activities such as infrastructure construction, mining, and agriculture have improved the country’s ...

China's economy is poised for steady growth, projecting a 4.8% increase in GDP for 2024, following a 5.2% rise in 2023. This growth is supported by robust public investment, a resurgence in private consumption, and increased net exports. However, challenges such as an aging labor force, escalating debt levels, and geopolitical tensions around Taiwa...

Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...